Drugs / Influenza Vaccine 2004-2005 Paediatric Formulation
Influenza Vaccine 2004-2005 Paediatric Formulation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00831675 | Sep 2004 → Apr 2006 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Vaccine 2004-2005 Paediatric Formulation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00831675 ↗ |
| Modality | Vaccine | “inactivated, split-virion influenza vaccine Fluzone®” NCT00831675 ↗ |
| Route | Intramuscular | “0.25 mL (Day 0 and Day 28), Intramuscular” NCT00831675 ↗ |